Minimal Residual Disease (MRD) Testing
News and reporting on minimal residual disease testing.
C2i Genomics, NovogeneAIT Genomics Partner to Launch Cancer Detection Platform in Southeast Asia
C2i's platform uses artificial intelligence pattern recognition and whole-genome analysis to detect minimal residual disease in blood samples from cancer patients.
Liquid Biopsy MRD Research at ASCO Showcases Uses in Variety of Tumor Types, Indications
Research presented at the ASCO meeting described efforts to expand the use of existing technologies into new directions.
Foresight Diagnostics Raises $12.5M in Series A to Commercialize MRD Detection Tech
The company, founded by Stanford University scientists, is advancing a technology called PhasED-Seq for cancer minimal residual disease detection.
Guardant Health Sues Natera for False Advertising, 'Misleading' Oncologists About MRD Tests
Guardant has asked the court to recover damages and to prevent Natera from further disseminating "deceptive" advertising regarding their competing assays.
F-Star Therapeutics to Use Inivata's RaDaR Assay in Clinical Studies
F-star will use the ctDNA assay to identify potential early biomarkers of clinical efficacy and evaluate treatment response for late-stage solid tumors.